Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Testimonials are not a guarantee of future results.
BPC 157 (),
Ingredient qualification, testing, documentation, and controls designed to provide confidence from raw material through finished product
Get your exact daily dose in micrograms and injection volume in milliliters
A Phase 2 trial (NCT01311518) was designed to test RGN-352 in ~75 heart attack patients, but was placed on FDA clinical hold in 2011 due to manufacturing (GMP) compliance issues at the contract site not safety concerns with the drug itself
US$ 26.17
US$ 21.97
US$ 29.10
US$ 24.94
US$ 28.02
